Compare Teladoc Health Inc (TDOC) vs TeraWulf Inc (WULF) Price & Performance

Teladoc Health (TDOC) trades at $6.96, up 2.2% today, but remains under pressure following a sharp 28% drop after its Q2 2026 revenue miss and lowered full-year guidance. The stock shows a bearish technical trend, with negative profitability metrics and a net loss of $200.32 million in 2025. Recent news is dominated by multiple law firm investigations into potential securities claims, adding to investor uncertainty despite some earnings beats in recent quarters.

The outlook is cautious. While valuation ratios like P/S of 0.48 and EV/EBITDA of 6.88 appear attractive, persistent net losses and the recent guidance cut signal fundamental challenges. The primary investment opportunity lies in a potential turnaround if cost controls and growth in Integrated Care stabilize results, but risks from ongoing legal probes and competitive pressures in virtual care are significant headwinds for shareholders.

WULF trades at $17.19, up 2.63% today, amid a bearish technical trend and volatile sector sentiment. The company reported a Q2 2026 net loss of $1.94 per share, missing estimates, while revenue trends remain pressured. Analyst consensus is unanimously bullish with a $39.25 price target, highlighting growth potential from high-performance computing expansion, including a major Anthropic deal.

Outlook hinges on execution of AI infrastructure build-out, but near-term risks include persistent losses, high capital demands, and competitive pressures. The stock offers significant upside if operational targets are met, yet investor caution is warranted given cash flow challenges and earnings volatility.